Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures

被引:52
|
作者
van Roozendaal, CEP
Gillis, AJM
Klijn, JGM
van Ooijen, B
Claassen, CJC
Eggermont, AMM
Henzen-Logmans, SC
Oosterhuis, JW
Foekens, JA
Looijenga, LHJ
机构
[1] Dr Daniel Den Hoed Canc Ctr, Acad Hosp, Div Endocrine Oncol, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Acad Hosp, Lab Expt Pathooncol, NL-3008 AE Rotterdam, Netherlands
[3] Dr Daniel Den Hoed Canc Ctr, Acad Hosp, Dept Surg Oncol, NL-3008 AE Rotterdam, Netherlands
[4] Dr Daniel Den Hoed Canc Ctr, Acad Hosp, Dept Pathol, NL-3008 AE Rotterdam, Netherlands
关键词
breast cancer; stromal fibroblast; insulin-like growth factor; genomic imprinting;
D O I
10.1016/S0014-5793(98)01211-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factors are involved in the paracrine growth regulation of human breast tumor cells. IGF2 is imprinted in most tissues, and shows expression of the paternal allele only. To investigate whether disruption of this monoallelic IGF2 expression is involved in breast cancer development, a series of primary tumors and adjacent, histologically normal, breast tissue samples, as well as matched primary in vitro fibroblast cultures were studied. Biallelic expression (partial) of IGF2 was found in the majority of in vivo samples, and corresponding fibroblast cultures, while monoallelic expression was found in a normal breast sample, In contrast, H19, a closely apposed, but reciprocally imprinted gene, assumed to be regulated by a common control element, showed retention of monoallelic H19 expression in all in vivo and in the majority of in vitro samples. These data indicate that IGF2, but not H19, is prone to loss of imprinting in breast cancer. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 50 条
  • [1] Examination of IGF2 and H19 loss of imprinting in bladder cancer
    Byun, Hyang-Min
    Wong, Hui-Lee
    Birnstein, Elliott Aaron
    Wolff, Erika M.
    Liang, Gangning
    Yang, Allen S.
    CANCER RESEARCH, 2007, 67 (22) : 10753 - 10758
  • [2] Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2
    Cui, HM
    Onyango, P
    Brandenburg, S
    Wu, YQ
    Hsieh, CL
    Feinberg, AP
    CANCER RESEARCH, 2002, 62 (22) : 6442 - 6446
  • [3] The prevalence of loss of imprinting of H19 and IGF2 at birth
    Rancourt, Rebecca C.
    Harris, Holly R.
    Barault, Ludovic
    Michels, Karin B.
    FASEB JOURNAL, 2013, 27 (08): : 3335 - 3343
  • [4] Regulation of imprinting at the H19/IGF2
    Bartolomei, MS
    Fedoriw, A
    Engel, N
    Wan, LB
    Schultz, R
    BIOLOGY OF REPRODUCTION, 2005, : 75 - 75
  • [5] Imprinting of canine IGF2 and H19
    Brabazon, D. C.
    Callanan, J. J.
    Nolan, C. M.
    ANIMAL GENETICS, 2022, 53 (01) : 108 - 118
  • [6] IGF2 but not H19 shows loss of imprinting in human glioma
    Uyeno, S
    Aoki, Y
    Nata, M
    Sagisaka, K
    Kayama, T
    Yoshimoto, T
    Ono, T
    CANCER RESEARCH, 1996, 56 (23) : 5356 - 5359
  • [7] MAINTENANCE OF NORMAL IMPRINTING OF H19 AND IGF2 GENES IN NEUROBLASTOMA
    WADA, M
    SEEGER, RC
    MIZOGUCHI, H
    KOEFFLER, HP
    CANCER RESEARCH, 1995, 55 (15) : 3386 - 3388
  • [8] A CHROMATIN MODEL OF IGF2/H19 IMPRINTING
    BANERJEE, S
    SMALLWOOD, A
    NATURE GENETICS, 1995, 11 (03) : 237 - 238
  • [9] PARENTAL IMPRINTING OF H19 AND IGF2 GENES
    DANDOLO, L
    M S-MEDECINE SCIENCES, 1995, 11 (10): : 1483 - 1486
  • [10] Imprinting of Igf2 and H19 at ectopic loci
    Ainscough, J
    Brenton, JD
    Koide, T
    Surani, MA
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 45 - 45